Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate

Condition:   Severe Malaria Interventions:   Drug: Argesun 60mg (1 step parenteral artesunate);   Drug: Artesun 60mg (2-step parenteral artesunate) Sponsors:   University of Oxford;   Shanghai Fosun Pharmaceutical Industrial Development Co, Ltd.;   University of Kinshasa;   National Institute for Medical Research, Tanzania Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials